Katarina Luptakova

Insider Reports History

Location
Waltham, MA
Signature
/s/ Kevin Brennan, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Katarina Luptakova:

Company Role Class Num Shares Value Price $ Report Date Ownership
Xilio Therapeutics, Inc. CHIEF MEDICAL OFFICER Restricted Stock Units 33,250 $49,062 $0.9837 01 Jan 2026 Direct
Xilio Therapeutics, Inc. CHIEF MEDICAL OFFICER Common Stock 33,250 $23,940 $0.7200 01 Jan 2026 Direct
Xilio Therapeutics, Inc. CHIEF MEDICAL OFFICER Stock Option (right to buy) 451,885 31 Dec 2025 Direct

Insider Reports Filed by Katarina Luptakova

Symbol Company Period Transactions Value $ Form Type Role Filing Time
XLO Xilio Therapeutics, Inc. 31 Dec 2025 3 $0 4 CHIEF MEDICAL OFFICER 05 Jan 2026, 16:30
XLO Xilio Therapeutics, Inc. 21 Nov 2025 11 $0 4 CHIEF MEDICAL OFFICER 25 Nov 2025, 16:10
XLO Xilio Therapeutics, Inc. 01 Jan 2025 3 $0 4 CHIEF MEDICAL OFFICER 03 Jan 2025, 16:15
XLO Xilio Therapeutics, Inc. 01 May 2024 1 $0 4 CHIEF MEDICAL OFFICER 03 May 2024, 16:10
XLO Xilio Therapeutics, Inc. 01 Jan 2024 1 $0 4 CHIEF MEDICAL OFFICER 03 Jan 2024, 16:15
XLO Xilio Therapeutics, Inc. 05 Sep 2023 1 $0 4 Chief Medical Officer 07 Sep 2023, 17:26
XLO Xilio Therapeutics, Inc. 05 Sep 2023 0 $0 3 Chief Medical Officer 07 Sep 2023, 17:23